Gfs Advisors, LLC Pfizer Inc Transaction History

Gfs Advisors, LLC

$470 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $9.05 Million - $10.6 Million	-358,446 Reduced 87.65%	50,518 $1.41 Million
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $1.83 Million - $2.1 Million	70,585 Added 20.86%	408,964 $11.3 Million
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $863,988 - $1.12 Million	33,065 Added 10.83%	338,379 $9.74 Million
Q3 2023 Oct 19, 2023	BUY	$32.09 - $37.51 $4.45 Million - $5.2 Million	138,696 Added 83.24%	305,314 $10.1 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $694,045 - $802,994	19,215 Added 13.04%	166,618 $6.11 Million
Q1 2023 Apr 27, 2023	SELL	$39.39 - $51.28 $129,790 - $168,967	-3,295 Reduced 2.19%	147,403 $6.01 Million
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $167,000 - $218,000	4,000 Added 2.73%	150,698 $0
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $459,480 - $560,910	-10,500 Reduced 6.68%	146,698 $6.42 Million
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $1.54 Million - $1.82 Million	-32,990 Reduced 17.35%	157,198 $8.24 Million
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $1.05 Million - $1.3 Million	-22,856 Reduced 10.73%	190,188 $9.85 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $2.03 Million - $3 Million	49,042 Added 29.9%	213,044 $12.6 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $171,561 - $220,385	-4,371 Reduced 2.6%	164,002 $7.05 Million
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $305,414 - $345,983	8,505 Added 5.32%	168,373 $6.59 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $131,448 - $148,247	3,925 Added 2.52%	159,868 $5.79 Million
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $440,398 - $560,004	-13,158 Reduced 7.78%	155,943 $5.74 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $88,265 - $103,555	-2,780 Reduced 1.62%	169,101 $6.21 Million
Q2 2020 Jul 29, 2020	BUY	$30.12 - $36.54 $2.8 Million - $3.4 Million	93,120 Added 118.23%	171,881 $5.62 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $834,199 - $1.19 Million	30,862 Added 64.43%	78,761 $2.57 Million
Q4 2019 Jan 17, 2020	SELL	$32.92 - $37.36 $67,749 - $76,886	-2,058 Reduced 4.12%	47,899 $1.88 Million
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $175,283 - $227,291	5,395 Added 12.11%	49,957 $1.8 Million
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $73,035 - $82,002	1,975 Added 4.64%	44,562 $1.93 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $518,190 - $590,794	-13,470 Reduced 24.03%	42,587 $1.86 Million
Q3 2018 Nov 27, 2018	SELL	$34.47 - $41.81 $882,432 - $1.07 Million	-25,600 Reduced 31.35%	56,057 $2.47 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $242,324 - $293,924	-7,030 Reduced 7.93%	81,657 $3.6 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $823,852 - $955,782	25,818 Added 41.07%	88,687 $3.15 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $337,422 - $358,017	10,145 Added 19.24%	62,869 $2.28 Million
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $1,023 - $1,126	-33 Reduced 0.06%	52,724 $1.88 Million
Q2 2017 Aug 07, 2017	BUY	N/A	52,757	52,757 $1.77 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gfs Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gfs Advisors, LLC with notifications on news.

Account